
To study the zzso manifestations of therapy with zzso and zzso killer zzso 

zzso survey of consecutive patients who were given the zzso Each patient was initially interviewed within 5 days before treatment, and a personal and family psychiatric history was obtained during this first zzso zzso tests and mood zzso instruments were administered at the beginning and end of zzso and zzso killer cell treatments, before zzso and at a follow-up visit 2 to 4 weeks after zzso 

National Cancer Institute zzso units at the National Institutes of zzso 

zzso samples of 44 patients with zzso cancer (age range, 28 to 69 zzso who were treated zzso with zzso zzso combined with zzso zzso killer cells between 30 December 1985 and 31 March zzso 

Of the 44 patients zzso 15 developed severe behavioral changes that necessitated acute intervention, and 22 patients had severe cognitive changes (all 22 became disoriented and many also had zzso evidence of cognitive zzso The zzso side effects were dose and time zzso appearing more frequently at the higher dose and almost zzso at the end of each treatment zzso All 39 patients who were seen at follow-up had a return to their baseline cognitive zzso None of the factors investigated was found to be zzso of the development of zzso zzso 

The development of clinically significant zzso changes during the administration of zzso and zzso killer cells was common and may be treatment zzso A marked zzso in the appearance of zzso changes after treatment onset was noted in almost all zzso Every patient studied recovered from the zzso side zzso 

